Session 4: Genome-wide SH/siRNA Screening
Session Chairperson: Christina Smolke, Stanford University, Stanford, CA
8:00 a.m.-10:00 a.m.
Genetic strategies for next generation of breast cancer therapies
Jose M. Silva, Columbia University, New York, NY
Functional genomics to identify cancer targets and resistance
William C. Hahn, Dana-Farber Cancer Institute, Boston, MA
Title to be announced
Stephen J. Elledge, Harvard Medical School, Boston, MA
|
Session 5: Systems Pharmacology and the LINCS Initiative
Session Chairperson: Jose M. Silva, Columbia University, New York, NY
10:30 a.m.-12:30 p.m.
Title to be announced
Todd R. Golub, Broad Institute of MIT and Harvard, Cambridge, MA
Interrogating gene regulatory networks to explore the boundary between chemistry and biology in cancer
Andrea Califano, Columbia University, New York, NY
Perturbed funtional genomics
Gordon B. Mills, University of Texas MD Anderson Cancer Center, Houston, TX
|
Session 6: Sensing and Pertubing Pathways
Session Chairperson: Todd Golub, Broad Institute of MIT and Harvard, Cambridge, MA
2:00 p.m.-4:30 p.m.
Super-resolution fluorescence microscopy of cells and tissues
Xiaowei Zhuang, Harvard University and Howard Hughes Medical Institute, Cambridge, MA
TMP-Tag: A chemical surrogate to the fluorescent proteins for live cell imaging
Virginia Cornish, Columbia University, New York, NY
Probing cell death with small molecules
Brent R. Stockwell, Columbia University, New York, NY
Predicting drug response from cancer cell lines
Adam A. Margolin, Broad Institute of MIT and Harvard, Cambridge, MA
|